Venture Life Group plc (VLG)

Currency in GBP
66.20
0.00(0.00%)
Closed·
VLG is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
65.4067.00
52 wk Range
52.0072.00
Key Statistics
Bid/Ask
65.00 / 70.00
Prev. Close
66.2
Open
66.2
Day's Range
65.4-67
52 wk Range
52-72
Volume
111.33K
Average Volume (3m)
229.9K
1-Year Change
11.2605%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
VLG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
150.00
Upside
+126.59%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Venture Life Group plc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 150.00
(+126.59% Upside)

Earnings

Latest Release
Mar 31, 2026
EPS / Forecast
0,03 / --
Revenue / Forecast
19,78M / --
EPS Revisions
Last 90 days

VLG Income Statement

Compare VLG to Peers and Sector

Metrics to compare
VLG
Peers
Sector
Relationship
P/E Ratio
−42.2x11.1x11.4x
PEG Ratio
−0.020.020.03
Price/Book
1.0x2.2x1.5x
Price / LTM Sales
2.3x1.7x0.9x
Upside (Analyst Target)
126.6%21.3%22.3%
Fair Value Upside
Unlock21.2%13.2%Unlock

Venture Life Group plc develops and commercializes healthcare products in the United Kingdom. The company offers oral healthcare products, including mouthwash, toothpaste, breath freshening capsules, and dental accessories under UltraDEX and Dentyl Dual Action brands; and proctology products, such as Procto-eze Plus range for treating the discomfort caused by haemorrhoids. It also provides dermatology products comprising Myco Clear, a fungal nail cleanser and solution brand; Rosa calma for normalizing and controlling the signs and symptoms related to rosacea; Bioscalin for the cosmetic treatment and prevention of hair loss, hair thinning, and baldness; and skincare solutions under the brand Lubatti. In addition, the company offers women’s healthcare products, including BV treatment gel and pessaries; intimate daily wash and soothing cream; moisture gel and plus pessaries; and thrush cream under Balance Activ name. Further, it provides glucose management products, such as Lift Glucose shots and tablets for the immediate treatment of hypoglycaemia and preventing hypos; Glucogel for the treatment of hypoglycaemia. Additionally, the company offers ENT care products comprising Earol, for the removal of ear wax; EarolSwim, an invisible ear plugs for protecting the ears from water ingress; and Baby Earol, an ear spray for babies under the Earol and EarolSwim brands. It also provides oncology support products, such as Pomi-T for the management of prostate-specific antigen levels in prostate cancer; Gelclair, a muco-adhesive oral rinse for the treatment of Oral Mucositis; and Xonrid, a hyaluronic acid-based topical gel, for the prevention and treatment of radiation-induced dermatitis. The company operates in Germany, the Netherlands, France, Sweden, Denmark, Lithuania, rest of Europe, the United States, Canada, Brazil, Ireland, and internationally. Venture Life Group plc was incorporated in 2005 and is headquartered in Bracknell, the United Kingdom.

Employees
43

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
21,90M17,98%14,50M
Other Institutional Investors
88,23M72,42%58,41M
Public Companies & Retail Investors
11,70M9,60%7,74M
Total
121,83M100,00%80,65M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Slater Investments Limited26,30%32 045 02221 214
Slater Growth Fund10,06%12 250 0008 110

FAQ

What Is the Venture Life Group (VLG) Stock Price Today?

The Venture Life Group stock price today is 66,20 GBP.

What Stock Exchange Does Venture Life Group Trade On?

Venture Life Group is listed and trades on the London Stock Exchange.

What Is the Stock Symbol for Venture Life Group?

The stock symbol for Venture Life Group is "VLG."

What Is the Venture Life Group Market Cap?

As of today, Venture Life Group market cap is 80,65M GBP.

What Is Venture Life Group's Earnings Per Share (TTM)?

The Venture Life Group EPS (TTM) is -0,01.

When Is the Next Venture Life Group Earnings Date?

Venture Life Group will release its next earnings report on Mar 31, 2026.

From a Technical Analysis Perspective, Is VLG a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Venture Life Group Stock Split?

Venture Life Group has split 1 times.

How Many Employees Does Venture Life Group Have?

Venture Life Group has 43 employees.

What is the current trading status of Venture Life Group (VLG)?

As of Sep 06, 2026, Venture Life Group (VLG) is trading at a price of 66,20 GBP, with a previous close of 66,20 GBP. The stock has fluctuated within a day range of 65,40 GBP to 67,00 GBP, while its 52-week range spans from 52,00 GBP to 72,00 GBP.

What Is Venture Life Group (VLG) Price Target According to Analysts?

The average 12-month price target for Venture Life Group is 150,00 GBP, with a high estimate of 150 GBP and a low estimate of 150 GBP. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +126,59% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.